10-22-2025 / Xia Sheng, Ph.D, Director of Bio-Bigdata Platform, GenScript / Scott Pritchett, Sr. Global Market Development Manager, GenScript

Glioblastoma (GBM) is an aggressive brain tumor with a five-year survival rate of only 5.5%. The highly suppressive tumor microenvironment (TME) presents a major barrier to CAR-T efficacy- but a revolutionary mix of multiplex editing and machine learning

Learn More

09-08-2025 / Rob Ford Field Application Scientist, GenScript

AI in Molecular Biology: Revolutionizing the Future of Biotech

Learn More

04-25-2025 / Dr. Mi Hue Jang | Principal Research Scientist

Learn More

02-19-2025 / Dr. Kangming Chen

The approval of messenger RNA (mRNA) based COVID-19 vaccines marked a pivotal scientific milestone, establishing mRNA as an innovative drug modality with immense therapeutic potential.

Learn More

12-17-2024 / Juliana Campo Garcia, Field Application Scientist, GenScript

RNA technologies have revolutionized the field of therapeutics, enabling breakthroughs in vaccine development and gene therapy.

Learn More

12-11-2024 / Dr. Yerim Kwon, Field Application Scientist, APAC region | Dr. Xing Gao, Global Product Manager, Molecular Biology, GenScript

Learn More

09-04-2024 / Dr. Xing Gao Global Product Manager, Molecular Biology, GenScript

Discover an informative webinar focusing on the revolutionary impact of DNA mutant libraries in biomedical research and development.

Learn More

03-27-2024 / Dr. Charlie Zou (Head of Project Management Dept.of Molecular Biology, GenScript) / Dr. Akbar Vahidi (CTO, Co-founder)

Unlock the potential of protein discovery and target identification with the combined power of Allozymes' microfluidics platform and GenScript's gene synthesis expertise. This webinar delves into the exciting partnership between these two innovators, show

Learn More